AU · rank #14 · 2026-07-27
SMHN
XETRA · EUR · $1.73B (USD)
The exact numbers the algorithm saw.
| Composite score Z-score blend of all factors below. | 0.756 |
|---|---|
| EPS revisions (30d) Change in consensus EPS estimate over the past 30 days ($/share). | +$0.13 |
| Net revisions (30d) Number of analysts revising upward minus downward. | 2 |
| Insider signal (90d) | — |
| Analyst upside Consensus target $107.69 | +36.1% |
| Momentum acceleration 3-month minus 12-month momentum. | -9.52% |
| Analyst rating 5 = Strong Buy, 1 = Strong Sell. | — |
| Gross margin TTM | +34.8% |
| 52w high | $118.40 |
| Market cap (USD) | $1.73B |
The AI research card
Independent qualitative review of each pick before the order is placed. On the rare day the research service is unavailable, the paper book trades on the quant ranking alone and no card appears here.
Summary
SÜSS MicroTec designs and manufactures specialized lithography and wafer bonding equipment for advanced semiconductor packaging, serving foundries and IDMs globally from its German base.
Rationale
A 36% analyst upside gap, 75% revision agreement, and sustained EPS upgrades over 30–90 days reflect analysts repricing a recovery cycle anchored by a record €330M backlog and management's reaffirmed €425–485M full-year guidance after a trough Q1.
Material risks
- 1The -64.6% Q1 earnings surprise and revenue collapse from €124.9M to €86.5M show that order-to-revenue conversion lags are long enough to produce violent near-term misses that can reset analyst targets before the backlog translates into sales.
- 2Export-control escalation targeting European semiconductor equipment shipments to China could impair order conversion on a backlog that likely includes Chinese packaging customers, directly undermining the recovery thesis.
AI verdict council
Each pick is reviewed independently by 3 models before any order. 3 of 3 voted to proceed.